Publications by authors named "Michael Quigley"

Claim this Profile
I
IgG3κ Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency.
Lihong Bu, Jae H Lee, Michael M Quigley, Reza Elahimehr, Jason D Theis

Am J Kidney Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of antineoplastic and immunomodulating agents on postvaccination SARS-CoV-2 breakthrough infections, antibody response, and serological cytokine profile.
Jacob New, Jason Cham, Lana Smith, Leah Puglisi, Tridu Huynh, Michael Quigley

J Immunother Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics.
Nathaniel L Matteson, Gabriel W Hassler, Ezra Kurzban, Madison A Schwab, Sarah A Perkins, Michael M Quigley

Cell· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization requiring intensive care unit due to SARS-CoV-2 infection correlated with IgM depression and IgG elevation.
Sara Tamizuddin, Jason Cham, Yasamin Ghiasi, Luis Borroto, Cindy Cao, Michael M Quigley

Future Sci OA· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment.
Natalie B Collins, Rose Al Abosy, Brian C Miller, Kevin Bi, Qihong Zhao, Michael Quigley

J Immunother Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline Science: OX40 agonistic antibody reverses immune suppression and improves survival in sepsis.
Jacqueline Unsinger, Andrew H Walton, Teresa Blood, Daniel J Tenney, Michael Quigley

J Leukoc Biol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of a Steroid Avoidance Immunosuppression Regimen in Renal Transplant Patients With De Novo or Preformed Donor-Specific Antibodies: A Single-Center Study.
Ryan Schutt, Jamie Case, Sunil M Kurian, Samantha R Spierling Bagsic, Bethany L Barrick, Michael M Quigley

Transplant Proc· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare worker seroconversion for SARS-CoV-2 at two large health systems in San Diego.
Laura Nicholson, Ronald W McLawhon, Sunil Kurian, Robert L Fitzgerald, Jamie Case, Michael Quigley

Am J Infect Control· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity.
Viralkumar Davra, Sushil Kumar, Ke Geng, David Calianese, Dhriti Mehta, Michael Quigley

Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor.
Dan You, Stephen Hillerman, Gregory Locke, Charu Chaudhry, Caitlyn Stromko, Michael Quigley

J Immunother Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.
Mauricio S Caetano, Ahmed I Younes, Hampartsoum B Barsoumian, Michael Quigley, Hari Menon

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors.
Rui Wang, Chan Gao, Megan Raymond, Gennaro Dito, Dominic Kabbabe, Michael Quigley

Clin Cancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VISTA is an acidic pH-selective ligand for PSGL-1.
Robert J Johnston, Linhui Julie Su, Jason Pinckney, David Critton, Eric Boyer, Michael Quigley

Nature· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Michael Quigley

J Immunother Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer.
Canan Kasikara, Viralkumar Davra, David Calianese, Ke Geng, Thomas E Spires, Michael Quigley

Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Michael Quigley

J Immunother Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Axial Length Corresponds to Decreased Retinal Light Dose: A Parsimonious Explanation for Decreasing AMD Risk in Myopia.
Michael G Quigley, Ian Powell, Walter Wittich

Invest Ophthalmol Vis Sci· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter-laboratory validation of the starch digestibility method for determination of rapidly digestible and slowly digestible starch.
Klaus Englyst, Aurelie Goux, Alexandra Meynier, Michael Quigley, Hans Englyst

Food Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity.
Karla R Wiehagen, Natasha M Girgis, Douglas H Yamada, Andressa A Smith, Szeman Ruby Chan, Michael Quigley

Cancer Immunol Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
Mark J Selby, John J Engelhardt, Robert J Johnston, Li-Sheng Lu, Minhua Han, Michael Quigley

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Fc-FcγR interactions in the antitumor activity of therapeutic antibodies.
Bryan C Barnhart, Michael Quigley

Immunol Cell Biol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
Mark J Selby, John J Engelhardt, Robert J Johnston, Li-Sheng Lu, Minhua Han, Michael Quigley

PLoS One· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal capillary flow and diabetic retinopathy.
Michael Quigley

Invest Ophthalmol Vis Sci· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system.
Maggie J Box, Eva L Sullivan, Kristine N Ortwine, Mark A Parmenter, Michael M Quigley

Pharmacotherapy· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells.
Mark J Selby, John J Engelhardt, Michael Quigley, Karla A Henning, Timothy Chen

Cancer Immunol Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis